What every intensivist should know about Tocilizumab

• Daniel Andrea Hofmaenner,
• Pedro David Wendel Garcia,
• Christoph Camille Ganter,
• Silvio D. Brugger,
• Philipp Karl Buehler,
• Sascha David

Affiliations

Daniel Andrea Hofmaenner

Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich

Pedro David Wendel Garcia

Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich

Christoph Camille Ganter

Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich

Silvio D. Brugger

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich

Philipp Karl Buehler

Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich

Sascha David

Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich